SYNTHESIS AND CHARACTERIZATION OF 3-[(5-(2-NITROPHENYL)-1, 3, 4-OXADIAZOL-2-YL) METHYL AMINO]-2-METHYL QUINAZOLIN-4(3H)-ONE
HTML Full TextSYNTHESIS AND CHARACTERIZATION OF 3-[(5-(2-NITROPHENYL)-1, 3, 4-OXADIAZOL-2-YL) METHYL AMINO]-2-METHYL QUINAZOLIN-4(3H)-ONE
Ramesh Dhani
Department of Pharmaceutical Chemistry, Oil Technological Research Institute, Jawaharlal Nehru Technological University Anantapur, Andhra Pradesh, India
ABSTRACTQuinazolinone is a heterocyclic chemical compound. There are two structural isomers, 2-quinazolinone and 4-quinazolinone, with the 4-isomer being the more common. The present survey aims to achieve the synthesis of quinazolinones and their derivatives of specific pharmacological properties. Various novel classes of structurally different quinazolinones have been designed and synthesized depicting potential interventions such as antibacterial, antifungal, antiviral, anticonvulsant, CNS depressant, anti-inflammatory, antihistaminic, anticancer and so on. At present some novel quinazolinone derivatives are synthesized and characterized by IR, H1 NMR, MASS Spectral studies.
Keywords: |
Quinazolinone, Anthranilic acid, 2-methyl 3-amino quinazoline 4(3H) one, Acetyl chloride, Chloro ethyl acetate, Ethanol
INTRODUCTION: Quinazoline is a bicyclic compound earlier known as benzo- 1, 3-diazine was prepared in the laboratory by Gabriel in 1903. Quinazolinone has been considered as a magic moiety possessing myriad spectrum of medicinal activities. Diversity of biological response profile has attracted considerable interest of several researchers across the globe to explore this skeleton for its assorted therapeutic significance. Various novel classes of structurally different quinazolinones have been designed and synthesized depicting potential interventions such as antibacterial, antifungal, antiviral, anticonvulsant, CNS depressant, anti-inflammatory, antihistaminic, anticancer and so on. Moreover, the nucleus constitutes an integral structural component in a number of drugs currently employed in several clinical therapies 1, 2.
MATERIALS AND METHODS:
- Preparation of 2-methyl 3amino quinqzolin-4(3H) one IV
Step 1: To a solution of anthranilic acid (0.1mol) is taken in a beaker and pyridine, acetyl chloride (0.2mol) was added. The reaction mixture is stirred continuously at 60o–90oC further followed by 5% of sodium bicarbonate. The solid obtained is recrystalized from ethanol and dried 5, 6.
Anthranilic acid: Acetyl Chloride 2-methyl-4H-benzo [d][1, 3]oxazin-4-one
Step 2: A mixture of 2-methyl-4H-benzo[d][1, 3]oxazin-4-one (0.01mole) compound was taken in round bottom flask and treated with hydrazine hydrate in ethanol was refluxed for 3hrs at 60o–90o and the resulting solution was poured in to the crushed ice. A white precipitated was obtained and recrystalized with ethanol and dried 6.
2-methyl-4H-benzo[d][1,3]oxazin-4-one 2-methyl3amino quinqzolin4(3H)one
- Preparation of ethyl 2-(4-oxo-2-methyl quinazolin-3(4H)-yl amino) acetate II: A mixture of 2-methyl 3amino quinqzolin-4(3H)-one compound (0.01mole) was taken in round bottom flask and treated with chloro ethyl acetate (0.01mole), DMA, acetone, potassium acetate, and refluxed for 6hrs and the resulting solution was poured in to crushed ice, precipitated was obtain, filtered and recrystalized with ethanol for two times and dried 7, 8.
I II
- Preparation of 2-(4-oxo-2-methylquinazolin-3(4H)-yl-amino)aceto hydrazide III: A Mixture of ethyl 2-(4- 0xo- 2-methyl quinazolin-3(4H)-yl-amino) acetate (0.01mole) was taken in round bottom flask and treated with hydrazine hydrate (0.01mole), in ethanol refluxed for 3hrs at 60o–90oC and the resulting solution was poured in to crushed ice, precipitated was obtain, filtered and recrystalized with ethanol for two times and dried 9.
II III
- Preparation of 3-((5-(2-nitrophenyl)-1, 3, 4-oxadiazol-2-yl)methylamino)-2-methylQuinazolin-4(3H)-one IV: A mixture of 2-(4-oxo-2-methylquinazolin-3(4H)-yl-amino) aceto hydrazide compound (0.1mol) treated with o-nitro benzoic acid in POCl3 was refluxed for 5hrs at 60o–90o and the contents were cooled and poured in to crushed ice.then it was neutralized with NaHCO3 solution and resulting solid was filtered and recrystalized with ethanol and dried.
III IV
Observations:
TABLE 1: PHYSICAL AND ANALYTICAL DATA OF SYNTHESIZED COMPOUNDS
S. no. | Compound | M.P | Yield | TLC | Rf Value |
1. | I | 220oc | 65% | hexane: ethyl acetate (1:1) | 0.33 |
2. | II | 477oc | 59% | hexane: ethyl acetate (1:1) | 0.62 |
3. | III | 501oc | 58% | hexane: ethyl acetate (1:1) | 0.30 |
4. | IV | 654oc | 65% | hexane: ethyl acetate (1:1) | 0.68 |
RESULTS AND DISCUSSION: The synthesized quinqzoline derivatives further studied for characterization of UV, IR, NMR and Mass. To study the structure-activity relationship and to optimize the structure
3-((5-(2-nitrophenyl)-1, 3, 4-oxadiazol-2-yl) methylamino)-2-methylquinazolin-4(3H)-one
- IR spectrum: The IR spectrum of the compound IV was recorded on FTIR spectrometer by KBr method. The FTIR spectra from the figure.1 and the table 2 shows bands at 3413.70cm-1, 3154.50cm-1, 1601.50cm-1, 1116.20 cm-1 , 912.50 cm-1 and 1681.20 cm-1 corresponds to 2o amine, aromatic C-H (stretch), Imine (C=N), C-O-C, C-NO2 and quinazolinone (C=O) respectively.
IR frequencies:
TABLE 2: IR VALUES OF COMPOUND IV
Compound | Types of vibration | Wave number [cm-1] | |
Observed value | Standard value | ||
IV | N-H stretch | 3413 | 3450 |
C-HStretch (aromatic) | 3154 | 3090 | |
C=O(quinazolinone) | 1681 | 1665 | |
C-O-C | 1116 | 1580 | |
C=N stretch | 1601 | 1163 | |
C-NO2 | 912 | 901 |
FIGURE 1: IR FOR COMPOUND 3-((5-(2-NITROPHENYL)-1,3,4-OXADIAZOL-2-YL) METHYL AMINO)-2-METHYL QUINAZOLIN-4(3H)-ONE IV
- Proton Magnetic Resonance Spectrum: The 1H NMR spectrum was recorded on JMR spectrometer using TMS as internal standard and DMSO as solvent. The 1H NMR spectrum of compound IV shown in figure 2 and table 3 showed singlets at δ 2.85 (3H, S, CH3) which represent the methyl group, singlets at δ 4.85 (2H, S, CH3) which represent the methylene group and at δ 6.7 (1H, S, N-H) which represent the N-H group. It showed multiplets at δ 7.1-7.9(8H, M, Ar-H) which represent the aromatic protons.
TABLE 3: 1H NMR VALUES OF COMPOUND IV
Compound | Types of proton | Nature of signal | ∆ value (ppm) | No.of 1H | |
Observed value | Standard value | ||||
IV | Aromatic
NH- CH2 CH3 |
Multiplet
Singlet Singlet Singlet |
7.1-7.9
6.7 4.8 2.8 |
6.5-7.7
5.0-6.0 4.22 2.6 |
8
1 2 3 |
FIGURE 2: 1H NMR FOR COMPOUND 3-((5-(2-NITROPHENYL)-1, 3, 4-OXADIAZOL-2-YL) METHYL AMINO)-2-METHYL QUINAZOLIN-4(3H)-ONE IV
CONCLUSION: The synthesized quinqzolinone derivatives characterized by IR, NMR and Mass spectral studies. By this studies find the structure-activity relationship and to optimize the structure.The synthesized quinazolinone derivative i.e., 3-((5-(2-nitrophenyl)-1, 3, 4-oxadiazol-2-yl) methyl amino)-2-methylquinazolin-4-(3H)-one was confirmed by physicochemical and spectral analysis.
ACKNOWLEDGEMENT: I am indebted to my parents and my sister for their inspiration and encouragement given to me during this work with deep appreciation for their determination and enthusiasm at each and every front of my life to transform my dreams into reality.
I am very thankful and prevailage to my deep sense of gratitude to Abdul Mohammed Bari, M. Pharm, Ph. D, Director of Bright laboratories, Hyderabad.
REFERENCES:
- Indian Pharmacopoeia. 3rd Delhi, The controller of publications.., pp 105-107, 1996.
- Gabriel, Schmidt DS. Synthesis of 5- chloro -2- methyl- 3- (5- methylthiazol-2-yl)-4(3H) quinazolinone and related compounds with potential biological activit Journal of Heterocyclic Chemistry. 2000; 37: 725-729.
- Weddige, J. Prakt. Synthesis and Biological screening of some heterocyclic derivatives of quinazolinones. Journal of Organic 2005; 36(11):141.
- Chen K, Wang K, Kirichian AM, et al., In silico design, synthesis, and biological evaluation of quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy. Molicular cancer therapy. 2006; 5(12): 3001-13.
- Dharti, G.; Harish, B.; Parekh, H. Synthesis of 2, 4-aryl substituted quinazoline 4(3H) one, .Journal of Medicinal Chemistry. 1997; 3: 169.
- Sridharet et al., Synthesis of novel 4,6-disubstituted quinazoline deriva- tives,their anti-inflammatory and anti-cancer activity against U937 leukemia cells. European Journal of Medicinal Chemistry. 2007; 14(5): 147-152.
- Kunes J, Bazant J, Pour M, Waisser K, Slosarek M, Janota J.Synthesis of quinazoline derivatives with antitubercular activity. IL Farmaco. 2000; 55: 725-729.
- Andotra, C. S. Langer, T. C. Sumita, D. Biological activity of some Quinazoline and quinazoline derivatives. Indian Journal of Pharmaceutical Science.1993; 55: 19-24. Veluchamy, Muthukumar, Agendran Pavalarani, Poongavanam Vasanthanathan and Rajappan Revathi. Synthesis, Analgesic and Anti-inflammatory Activities of Some Novel 2, 3-Disubstituted Quinazolin-4(3H) ones. Biologucal Pharm. Bull. 2003; 26(4): 557-559.
How to cite this article:
Behera S, Ghanty S, Ahmad F, Santra S and Banerjee S: UV-visible Spectrophotometric Method Development and Validation of Assay of Paracetamol Tablet Formulation. Int J Pharm Sci Res. 3(12); 4954-4958.
Article Information
57
4954-4958
635
1594
English
Ijpsr
Ramesh Dhani
Department of Pharmaceutical Chemistry, Oil Technological Research Institute, Jawaharlal Nehru Technological University Anantapur, Andhra Pradesh, India
dhaniramesh1@gmail.com
28 August, 2012
03 October, 2012
29 November, 2012
http://dx.doi.org/10.13040/IJPSR.0975-8232.3(12).4954-58
01 December, 2012